Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 Next >
Europe's pharma industry braces for tariffs as carve-out hopes fade
Tags Bavarian Nordic A/S Health care industry Pharmaceuticals
From CNBC.com News
Hims & Hers shares rise as company adds new weight-loss medications to platform
Tags Hims & Hers Health Inc Health & Science LILLY DRN
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Breaking News: Markets Johnson & Johnson Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Tags Healthy Returns Biotech and Pharmaceuticals AstraZeneca PLC
From CNBC.com News
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Tags LILLY DRN Health & Science Social issues
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Health care industry Companies Novo Nordisk A/S
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotechnology Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Pharmaceuticals Biotech and Pharmaceuticals LILLY DRN
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Science LILLY DRN Social issues
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Investment strategy Politics Business
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Business News Breaking News: Business Roche Holding AG
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags LILLY DRN Biotechnology Business
From CNBC.com News
Beijing pledges greater market access as top global CEOs gather at the China Development Forum
Tags China Politics Mastercard Inc China Markets
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags Health care industry Hims & Hers Health Inc Retail industry
From CNBC.com News
Roche and Zealand Pharma strike $5.3 billion deal for new obesity drug candidate
Tags Biotechnology Roche Holding AG Pharmaceuticals
From CNBC.com News
White House: Stock market plunge is not as 'meaningful' as business activity
Tickers CEOS
Tags Breaking News: Politics Republicans CEOs
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Companies Amgen Inc Health care industry
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Companies Health care industry Biotechnology
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Zealand Pharma A/S Social issues GE HealthCare Technologies Inc
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Health care industry Companies Breaking News: Business
From CNBC.com News
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Tags Health care industry Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Business News Breaking News: Business Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall
Tags Health & Science Science LILLY DRN
From CNBC.com News
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
Tags Health & Science LILLY DRN Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Science LILLY DRN Social issues
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags Bosch Ltd LILLY DRN World Economy
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Earnings NVIDIA Corp Business
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Companies Health care industry Biotechnology
From CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
Tags Companies Health care industry Business
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Earnings Health & Science Health care industry
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.